FGFR Fusions in Cancer: From Diagnostic Approaches to Therapeutic Intervention

被引：92

作者：

De Luca, Antonella ^{[1
]}

Esposito Abate, Riziero ^{[1
]}

Rachiglio, Anna Maria ^{[1
]}

Maiello, Monica Rosaria ^{[1
]}

Esposito, Claudia ^{[1
]}

Schettino, Clorinda ^{[2
]}

Izzo, Francesco ^{[3
]}

Nasti, Guglielmo ^{[4
]}

Normanno, Nicola ^{[1
]}

机构：

[1] Ist Nazl Tumori IRCCS Fdn G Pascale, Cell Biol & Biotherapy Unit, I-80131 Naples, Italy

[2] Ist Nazl Tumori IRCCS Fdn G Pascale, Clin Trials Unit, I-80131 Naples, Italy

[3] Ist Nazl Tumori IRCCS Fdn G Pascale, Hepatobiliary Unit, Div Surg Oncol, I-80131 Naples, Italy

[4] Ist Nazl Tumori IRCCS Fdn G Pascale, SSD Innovat Therapies Abdominal Canc, I-80131 Naples, Italy

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2020年 / 21卷 / 18期

关键词：

fibroblast growth factor receptors; FGFR fusions; next generation sequencing; cancer; FGFR inhibitors; GROWTH-FACTOR RECEPTOR; UNIQUE MOLECULAR SUBTYPE; GENE FUSIONS; UROTHELIAL CARCINOMA; TARGETED THERAPY; OPEN-LABEL; PHASE-II; IDENTIFICATION; MUTATIONS; CHOLANGIOCARCINOMA;

D O I：

10.3390/ijms21186856

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Fibroblast growth factor receptors (FGFRs) are tyrosine kinase receptors involved in many biological processes. Deregulated FGFR signaling plays an important role in tumor development and progression in different cancer types.FGFRgenomic alterations, includingFGFRgene fusions that originate by chromosomal rearrangements, represent a promising therapeutic target. Next-generation-sequencing (NGS) approaches have significantly improved the discovery ofFGFRgene fusions and their detection in clinical samples. A variety of FGFR inhibitors have been developed, and several studies are trying to evaluate the efficacy of these agents in molecularly selected patients carryingFGFRgenomic alterations. In this review, we describe the most frequentFGFRaberrations in human cancer. We also discuss the different approaches employed for the detection ofFGFRfusions and the potential role of these genomic alterations as prognostic/predictive biomarkers.

引用

页码：1 / 18

页数：18

共 71 条

[31] Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study [J].

Konecny, Gottfried E. ;

Finkler, Neil ;

Garcia, Agustin A. ;

Lorusso, Domenica ;

Lee, Paula S. ;

Rocconi, Rodney P. ;

Fong, Peter C. ;

Squires, Matt ;

Mishra, Kaushal ;

Upalawanna, Allison ;

Wang, Yongyu ;

Kristeleit, Rebecca .

LANCET ONCOLOGY, 2015, 16 (06) :686-694

[32] Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated Cholangiocarcinoma [J].

Kongpetch, Sarinya ;

Jusakul, Apinya ;

Lim, Jing Quan ;

Ng, Cedric Chuan Young ;

Chan, Jason Yongsheng ;

Rajasegaran, Vikneswari ;

Lim, Tse Hui ;

Lim, Kiat Hon ;

Choo, Su Pin ;

Dima, Simona ;

Popescu, Irinel ;

Duda, Dan G. ;

Kukongviriyapan, Veerapol ;

Khuntikeo, Narong ;

Pairojkul, Chawalit ;

Rozen, Steven G. ;

Tan, Patrick ;

Teh, Bin Tean .

JCO GLOBAL ONCOLOGY, 2020, 6 :628-638

[33] Landscape of gene fusions in epithelial cancers: seq and ye shall find [J].

Kumar-Sinha, Chandan ;

Kalyana-Sundaram, Shanker ;

Chinnaiyan, Arul M. .

GENOME MEDICINE, 2015, 7

[34] Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE [J].

Kurobe, Masahiro ;

Kojima, Takahiro ;

Nishimura, Kouichi ;

Kandori, Shuya ;

Kawahara, Takashi ;

Yoshino, Takayuki ;

Ueno, Satoshi ;

Iizumi, Yuichi ;

Mitsuzuka, Koji ;

Arai, Yoichi ;

Tsuruta, Hiroshi ;

Habuchi, Tomonori ;

Kobayashi, Takashi ;

Matsui, Yoshiyuki ;

Ogawa, Osamu ;

Sugimoto, Mikio ;

Kakehi, Yoshiyuki ;

Nagumo, Yoshiyuki ;

Tsutsumi, Masakazu ;

Oikawa, Takehiro ;

Kikuchi, Koji ;

Nishiyama, Hiroyuki .

PLOS ONE, 2016, 11 (12)

[35] Molecular targeted therapies: Ready for "prime time" in biliary tract cancer [J].

Lamarca, Angela ;

Barriuso, Jorge ;

McNamara, Mairead G. ;

Valle, Juan W. .

JOURNAL OF HEPATOLOGY, 2020, 73 (01) :170-185

[36] The Precise Sequence of FGF Receptor Autophosphorylation Is Kinetically Driven and Is Disrupted by Oncogenic Mutations [J].

Lew, Erin D. ;

Furdui, Cristina M. ;

Anderson, Karen S. ;

Schlessinger, Joseph .

SCIENCE SIGNALING, 2009, 2 (58) :ra6

[37] Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma [J].

Loriot, Y. ;

Necchi, A. ;

Park, S. H. ;

Garcia-Donas, J. ;

Huddart, R. ;

Burgess, E. ;

Fleming, M. ;

Rezazadeh, A. ;

Mellado, B. ;

Varlamov, S. ;

Joshi, M. ;

Duran, I. ;

Tagawa, S. T. ;

Zakharia, Y. ;

Zhong, B. ;

Stuyckens, K. ;

Santiago-Walker, A. ;

De Porre, P. ;

O'Hagan, A. ;

Avadhani, A. ;

Siefker-Radtke, A. O. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (04) :338-348

[38] Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention [J].

Lowery, Maeve A. ;

Ptashkin, Ryan ;

Jordan, Emmet ;

Berger, Michael F. ;

Zehir, Ahmet ;

Capanu, Marinela ;

Kemeny, Nancy E. ;

O'Reilly, Eileen M. ;

El-Dika, Imane ;

Jarnagin, William R. ;

Harding, James J. ;

D'Angelica, Michael I. ;

Cercek, Andrea ;

Hechtman, Jaclyn F. ;

Solit, David B. ;

Schultz, Nikolaus ;

Hyman, David M. ;

Klimstra, David S. ;

Saltz, Leonard B. ;

Abou-Alfa, Ghassan K. .

CLINICAL CANCER RESEARCH, 2018, 24 (17) :4154-4161

[39] Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma [J].

Mazzaferro, Vincenzo ;

El-Rayes, Bassel F. ;

Busset, Michele Droz Dit ;

Cotsoglou, Christian ;

Harris, William P. ;

Damjanov, Nevena ;

Masi, Gianluca ;

Rimassa, Lorenza ;

Personeni, Nicola ;

Braiteh, Fadi ;

Zagonel, Vittorina ;

Papadopoulos, Kyriakos P. ;

Hall, Terence ;

Wang, Yunxia ;

Schwartz, Brian ;

Kazakin, Julia ;

Bhoori, Sherrie ;

de Braud, Filippo ;

Shaib, Walid L. .

BRITISH JOURNAL OF CANCER, 2019, 120 (02) :165-171

[40]

Meric-Bernstam F, 2018, ANN ONCOL, V29

← 1 2 3 4 5 6 7 8 →